GATTEFOSSE SAS

Overview

GATTEFOSSE SAS is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering SUPPOCIRE.

API / Drug Master Files

GATTEFOSSE SAS holds 1 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SUPPOCIREActive1985-08-12
• MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN SAINT-PRIEST, FRANCEInactive1991-01-17

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to GATTEFOSSE SAS in our records. PharmaTek screens the full directory against live FDA enforcement data.